Long-Term Effects of Bevacizumab on Vestibular Schwannoma Volume in Neurofibromatosis Type 2 Patients.

Killeen, Daniel E; Klesse, Laura; Tolisano, Anthony M; Hunter, Jacob B; Kutz, Joe Walter

Killeen, Daniel E; Klesse, Laura; Tolisano, Anthony M; Hunter, Jacob B; Kutz, Joe Walter.

Afiliação

Killeen DE; Department of Otolaryngology - Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Klesse L; Department of Pediatrics and Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Tolisano AM; Department of Otolaryngology - Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Hunter JB; Department of Otolaryngology - Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Kutz JW; Department of Otolaryngology - Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States.

J Neurol Surg B Skull Base ; 80(5): 540-546, 2019 Oct.

Article em En | MEDLINE | ID: mdl-31534897

Palavras-chave

Avastin; acoustic neuroma; bevacizumab; neurofibromatosis type 2; vestibular schwannoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Neurol Surg B Skull Base Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google